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Discussion: Session 3*
Policy Issues in Applying
Epidemiologic Evidence
Dr. Enterline opened the discussion by asking
Dr. Hunt about the interagency criteria for
epidemiologic studies. The draft he had indicates
that an epidemiologist should make his data avail-
able to other epidemiologists. The idea is sound
because, after all, what an epidemiologist says
about his data ought to be verifiable. But it is not
clear whether this is a two-way street between
government and nongovernment epidemiologists.
Could she clarify whether government investiga-
tors will make data available to fiongovernment
people, as well as the reverse? Dr. Hunt replied
that the "criteria" in question refer to the Inter-
agency Regulatory Liaison Group (IRLG) Guide-
lines for documentation of epidemiological studies
mentioned in her talk. Documentation is a key
point, including exchange of data or the availabil-
ity of data. The IRLG Guidelines were written in
the context that when clarification of a study is
needed, evaluation ofthe study is best made ifthe
back-up data are available. Such data are usually
not possible to obtain from published studies.
When studies are germane to the regulatory
process, it is reasonable for best evaluation of
them for data to be shared. In terms of the
availability of federal data to anybody else, as you
well know we have the Freedom of Information
Act under which we are operating. According to
the guidelines, supporting documentation should
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be provided for any instruments, analytic methods
used, and computer programs. If established pro-
cedures are involved, references should be given.
Ifnew or modified measures are used in the study,
a description of the method, including its limita-
tions and advantages for the study, should be
stated. Data and supporting documentation under-
lying any study submitted should be available
upon request for independent scientific analysis.
Dr. Enterline pointed out that these guidelines
appliedto people submittingevidenceforregulatory
purposes.
Later the discussion on the IRLG Guidelines
was reopened by Dr. Jess Kraus (University of
California-Davis) and by Dr. Gary Spivey (Uni-
versity of California-Los Angeles). They asked
for time to present a statement, which was pre-
sented by Dr. Kraus. He stated that he and Dr.
Spivey, after listening to the comments on the
IRLG, felt that an expression ofconcern should be
raised on the guidelines, and particularly to this
audience, whose commitment, interest and inclina-
tion is in the field of epidemiologic research. The
IRLG Guidelines may very well have a profound
impact on the conduct of epidemiologic research in
the future, hence they felt a briefstatement was in
order. In the past decade or so, there have been
three very important events that have shaped an
important and significant amount of epidemiologic
research that has been undertaken as of late. The
first was the introduction of guidelines and then
regulations on the conduct of human experimenta-
tion that has since extended to survey research.
The second very important development has been
the work toward the initiation of the American
College of Epidemiology, about which there have
been raised many comments. The third, he and
Dr. Spivey believe, is the development of the
IRLG Guidelines which could impact importantly
on the future conduct of epidemiologic research.
Although these views represent only two members
89of the profession, they believe they express many
of the concerns heard whenever the subject has
been raised. For the record, it should be noted
that the way in which the guidelines were devel-
oped and introduced left much to be desired. As
far as the Society for Epidemiologic Research was
concerned, they were approached only a short
time before the guidelines were published; the
Epidemiology Section ofthe American Public Health
Association was not privy to them before they
were published.
In the opinion of many of their colleagues, the
guidelines show remarkable similarity to recom-
mendations published, after several revisions, on
the conduct of human studies and research involv-
ing human subjects. These recommendations today
have taken on the force ofregulation, and in many
states, law. While there was no doubt ample need
for such standards, their adoption as rule and
regulation has, in their opinion, stifled much perti-
nent epidemiologic research. Often research ofthe
past 10 years bears little resemblance to that of
decades earlier because of newer developments,
techniques or innovations in the design or execu-
tion of epidemiologic studies. The IRLG Guide-
lines will serve to hinder, they felt, such advances
in the future. Like it or not, investigators who will
want to qualify for federal funding will adopt these
guidelines for expediency rather than be influenced
by principles of scientific inquiry. The basis for
these guidelines was the need on the part of
regulators to be able to interpret epidemiologic
studies, as they understood it, yet these same
people may follow such guidelines blindly without
increasing their level of understanding. Would it
not be more profitable for those translating
epidemiologic findings into policy or regulation to
be educated in epidemiologic principles rather than
blindfolded by rigid protocol? Dr. Hunt in her
presentation mentioned on several occasions the
need for creativity, ingenuity, and innovation in
approaching environmentally related epidemiologic
research. Yet the guidelines will result, no doubt,
in suppression of methodologic approaches that
will surely be needed to address these problematic
areas.
In the event that the IRLG formally adopts
these guidelines and professional epidemiologists
choose to reject them, will this set up a confronta-
tion that could lead to discrimination in selection of
federally funded research? For example, will in-
vestigators be required to adopt these guidelines
as a condition for federal funding of environmen-
tally related research? One approach, that seems
more productive than guidelines for interpreta-
tion, would be to examine more carefully the
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credentials of the investigators who purport to be
epidemiogists and who submit applications under
this guise.
Dr. Altshuler stated that he thought there is too
much emphasis on the Interagency Regulatory
Liaison Group as a monolithic unit to decide things
or agree on one optimum way of doing research.
There is much advantage in allowing several
approaches, although he agreed with the idea of
coordination.
Dr. William Lloyd (Occupational Safety and
Health Administration, Washington) indicated he
was a member of the IRLG Epidemiology Com-
mittee. What he had heard from Dr. Kraus he
could only consider as a complete misinterpreta-
tion of what the guidelines say. There is nowhere
implied in that document that it is going to have
any force of law or that it is going to be a
standard. If there is anything missing in that
document, it is the reason why these guidelines
were considered to be needed. This was that in
regulatory hearings many people spoke as profes-
sionals and called themselves epidemiologists, but
who presented testimony that was, to put it
politely, ridiculous. Even people from some of our
schools ofpublic health came in and said they were
professional epidemiologists, yet presented in tes-
timony things that they wouldn't accept from a
first semester candidate for a Master's degree.
Now when you have circumstances like this, peo-
ple who are making regulations have to have some
way to interpret what is going on. Thus it was not
unreasonable at all to develop guidelines for those
people, and that is exactly what they are. It is to
give those responsible for regulation guidance, so
that they know the appropriate kinds of questions
to ask of these people when they come in to
present their testimony. He believed that much of
the argument against the guidelines of the IRLG
committee had come from a single epidemiologist
in the United States. The guidelines are not an
attempt to suppress anybody or any new ap-
proaches. The committee is hoping that they will
improve epidemiological investigation by having
these kinds of guidelines.
Dr. Hunt added that at least 40% ofthe commit-
tee was in this auditorium. It included Dr. Lloyd,
Dr. Williamson, Dr. Waxweiler, and herself. She
thought Charles Poole of the Office of Toxic
Substances was also present. In terms of the
development ofthe guidelines, to hear an interpre-
tation of the manner by which they were devel-
oped distorted the way it was, was beyond her.
The concern of the IRLG was, as Dr. Lloyd has
pointed out, the uneven quality of epidemiologic
studies being presented to regulatory agencies and
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decisions had in interpreting them. One obvious
misconception also was that it is epidemiologists
who are making decisions about regulations.
In fact, somebody else, who is not an epidemiol-
ogist, is making such decisions based on these
studies, whether we like it or not. We are not
going to be able to send to schools of public health
for training judges, lawyers and policy-makers
who are administering the regulatory agencies. It
soon became evident over the period of about
three or four months the IRLG worked together
that they wanted to be sure that the deliberations
reached a larger audience. It happened that the
Society for Epidemiologic Research was having its
annual meeting and Dr. Williamson went to that
annual meeting and requested an audience with
the executive committee. She presented the draft
as it stood at that point. They were provided with
enough copies for the guidelines to be sent to the
entire membership. The comment period, when it
was published in the Federal Register, was ex-
tended at the request ofthe Epidemiology Section
of the American Public Health Association, and
that comment period closed early in March.
There was now a sheaf of responses which are
being closely evaluated for suggested changes, for
rewording, etc. Some comments from these re-
sponses were as follows. Trade organizations and
industry representatives stated that this was a
good route to go because the guidelines introduce
some clarity in judging studies. Within depart-
ments of universities there were sometimes dia-
metrically opposite letters from faculty: one fac-
ulty person saying the guidelines were great;
another faculty person saying they would lead to
the decline of epidemiology. At this stage, the
group was going through the process ofpresenting
to the public every opportunity to comment on
these guidelines and how they will be used. Those
who are making decisions on epidemiology studies,
very few of whom are epidemiologists, and those
who are presenting epidemiology studies to a
regulatory agency, are to use the guidelines to
document the studies and describe them in a
manner which will allow for minimum misunder-
standing of the study by the regulators.
Dr. Marvin Hines (State Epidemiologist, North
Carolina) emphasized the role that state epidemi-
ologists could play in dealing with environmental
problems, particularly because they are closer to
the problems at issue. The need is for flexibility
and quick response to emergencies, such as the
case in North Carolina of PCBs being deliberately
dumped along 200 miles of roads. This issue still
has not been resolved, perhaps because of federal
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intervention. Another area where state epidemiol-
ogists can contribute is in carrying out studies of
local problems, such as byssinosis in textile mills.
Despite opposition from the large textile compa-
nies, he was able to carry out a study which forms
the basis of the current OSHA standards for
cotton dust. In another case, their staff investi-
gated safe return times for workers after tobacco
fields had been sprayed with parathion. He con-
cluded that state epidemiologists could contribute
greatly in environmental regulation, but they were
too often not considered in the process of regula-
tion nor in research potential.
Dr. Philip Landrigan (NIOSH, Cincinnati) com-
mented on the relationship ofair lead to blood lead
measurements. He shared Dr. Billick's position
that leaded gasoline is a public health hazard. He
noted that 100,000 to 150,000 tons of lead from
gasoline are emitted each year in the air in the
United States, most in respirable particulate form.
Thus it is a public health threat not to be taken
lightly, and the Public Health Service and the
Center for Disease Control support EPA in their
continuing efforts to reduce the lead content of
gasoline. He was, however, puzzled concerning the
significance of the next relationship discussed by
Dr. Billick. He did not dispute the reality of the
parallel decline in air lead levels in New York City
and in the blood lead levels of children living
there, but he was not sure that he accepted Dr.
Billick's implication of a causal relationship. First,
the air lead measurements were taken at the
entrance to Holland Tunnel, hardly typical of
general urban air. Second, during the years 1972-76
when a decline in air lead levels was demonstrat-
ed, there was an upsurge in activity sponsored by
CDC and the New York City Health Department,
in which parents were being educated in the
hazards oflead-based paint. As a result, thousands
of children were screened for blood lead and free
erythrocyte protoporphyrin, and thousands ofhomes
were deleaded.
Thus, although lead in air constitutes a significant
source, he thought Dr. Billick had overstated the
case in implying that reduction air lead levels was
the major cause ofthe reduction in children's blood
levels. He considered that it was particularly
important to discuss the issue because HUD is one
of the major holders in the country of what might
politely be called low-cost urban residential hous-
ing. It is important that HUD recognize and
vigorously address the problem of lead exposure
from lead paint in old housing.
Dr. Billick replied that he hoped he had not
implied a causal relationship between changes in
air and blood lead. In arguments about the use of
91statistics to prove causal relationships, one special
case of Murphy's Law is Billick's Law, which is
that statistics prove causal relationships when it is
your theory. Dr. Landrigan had focused on the
question of the connection between air lead and
blood lead rather than on the more important
connection between lead from gasoline and blood
lead. Dr. Billick agreed that air exposure may not
be the main route by which lead consumption in
gasoline is related to lead uptake. He thought that
exposure comes from other routes, but ultimately
from lead in gasoline. He disputed that hundreds
of thousands have had homes deleaded in New
York City. Ifyou look at the New York City data,
lead values in children are generally very low if
one considers the population that was screened.
He added that he had found the same relationship
of lead in gasoline to blood lead in several cities,
not just New York City.
As far as HUD being a major owner of slum
properties, when one looks into the property
holdings of HUD, it is not as much as one might
think. HUD has very little legal authority in the
area of private dwellings, and it can only influence
those areas where it provides funds. As far as he
was aware, HUD is the only agency that does
have a preventive regulation for paint, that is, for
the removal of peeling and flaking paint. Whether
the regulation is adequate, well, that is a discus-
sion that could go on forever.
Dr. Landrigan responded that he appreciated
Dr. Billick's clarifying his thoughts on the rela-
tionship between air lead and blood level. Dr.
Landrigan said that according to the Center for
Disease Control, over 700,000 children had been
tested for lead in New York City between 1973
and 1980. He added that although the number of
cases of clinical lead poisoning in New York has
been declining dramatically over the past decade,
about a year ago, in the North Bronx, at least,
there has been an upturn. Montefiore Hospital had
received 39 cases of acute lead poisoning in the
past 15 months, or more than they had found in
the whole decade of the 1970s. The apparent
reason for the increase is that black, poor, and
Hispanic families are moving into houses along the
Grand Concourse in the Bronx, previously very
wealthy, upper-class houses, which are now for
the first time being subdivided into apartments; in
these homes children are for the first time coming
in contact with and eating lead-based paint. For
virtually every one of the 39 cases, the social staff
at Montefiore Hospital has been able to trace the
source of the children's exposure to paint. Mean-
while, the content of lead in the air in the Bronx
continues to decline.
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Dr. Robert S. Chapman, (EPA, Research Tri-
angle Park, North Carolina) had a comment and a
question. His comment was with regard to the
Alsea study in Oregon. The design of that study
was such that it could never adequately address
the question that it purported to address. But with
all the press it received, many began to think that
the Alsea study exonerated the environmental
challenge that it was purporting to look at. He did
not think that was correct. Studies like the Alsea
study neither exonerate nor incriminate the effects
of environmental agents. The tendency is to inter-
pret inconclusive studies as though they show no
effect when they don't really do so.
His question was for Dr. Kuller: In light of data
showing an interesting social class or income-
specific effect for cancer, is there a residual effect
of income on cancer rate after smoking is adjusted
for? With adjustment for smoking, perhaps match-
ing for income or some other aspect of socioeco-
nomic status is needed. At the same time he was
concerned that vigorous matching might tend un-
wittingly to confine cases and controls to the same
geographic area, and thus to diminish the investi-
gator's ability to detect pollution-related effects.
He thought the same question would apply to race
or ethnic factors as well. Dr. Kuller replied that
the nature of factors contributing to cancer risk is
often related to personal behavior, that is, related
to diet, alcohol, cigarette smoking or perhaps even
genetic factors. When one is investigating an
environmental exposure to cancer in a community
it is important to control for these factors very
carefully. He agreed that even if you adjust for
cigarette smoking, socioeconomic factors remain
which can influence cancer risk. For example, for
stomach cancer, which is not smoking-related,
socioeconomic and ethnic variables are important,
and studies of the effect of environmental agents
must take them into account.
Dr. David Parkinson (University of Pittsburgh
and International Steelworkers Union) stated that
in the last 10 years, since the passage of the
OSHA Act, a total of 23 standards have been set
for the workplace, in his opinion a sorry record for
the Administration. These standards were primar-
ily single-substance standards, such as lead and
asbestos, and very few of them were for sub-
stances on which we did not already have tremen-
dous amounts of data. We have not yet gotten
around to dealing with any of the exotic chemicals
which have been developed over the last 20 years.
His question was: How did the panel view the
single toxic substance approach for standard set-
ting? Could it ever really be a success? What about
the generic standards that have been passed or are
Environmental Health Perspectivesproposed? Are they more successful or less suc-
cessful than taking the single source approach? He
was thinking in particular of the coke oven stan-
dard which he regarded as a generic standard, and
which he thought is successful. He was also
thinking about the standard for carcinogens, which
again is a generic standard. What can environmen-
tal epidemiology do when dealing with a multitoxic
substance world, and you are having to protect the
health of workers living in that particular envi-
ronment?
Dr. Bundy began by disagreeing about the 23
standards since OSHA was passed. When the law
went into effect there were 400 standards that
were incorporated. Perhaps they were not appro-
priate in all cases, but he did not view the few new
standards as being way behind time. He believed
that where generic standards can be applied, they
may be appropriate. In this case, far too tight
standards may be required in some places, and for
that industry generic standards are a disservice.
He did not think one could say individual stan-
dards are the best thing or generic standards are
the best thing in every case. At times the combi-
nation ofthe two will prove better. He agreed that
the coke oven standard is probably a generic
standard, although citations are not issued on a
generic basis. He pointed out that it is going to be
several years before we will find out whether some
of these standards are really correct or not. His
plea to the epidemiologists in the group was to
prove the standards are either right or need to be
tightened.
Dr. Hunt agreed that the real world is a
multitoxic world, yet we have developed the
strength of epidemiologic methods on the basis of
studies of single effects, particularly in terms of
cancer. The methodology ofepidemiology currently
may be quite different from what we are going to
have to develop to study a multitoxic world. In
terms of studying the reproductive system, one of
the more sensitive biological systems to examine,
all ofthe components, the sperm cycle, the ovarian
cycle, fertility, early reproductive loss, fetal deaths,
stillborns, infant mortality, development abnor-
malities in subsequent life, all have to be evaluat-
ed. This series of endpoints may be affected by
several environmental factors, in contrast to dif-
ferent kinds of cancer, which often tend to be
agent-specific in etiology. The creativity that she
believed was present at this symposium needs to
be directed toward how to deal with the multitoxic
world, how to use epidemiologic methods in this
complex situation.
Dr. William Morton (University of Oregon Med-
ical School) disputed the claim of Dr. Bundy that
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the major cause of lung cancer is smoking. About
20 years ago Hammond and Horn showed that if
you stopped smoking for a year or more the lung
cancer risk goes down. For the past 15 years or so
smoking prevalence in this country has plateaued
in males. Based on that experience, he would have
expected the lung cancer death rate would have
plateaued in males with a slight lag. This roughly
has happened for coronary heart disease, which is
another major smoking-related disease, and which
also shows an effect of stopping smoking. Since
that has not happened for lung cancer, we should
expect something else is going on. Clearly, smok-
ing is a risk factor, but it is a plausible hypothesis
that its relative importance has been superseded
by some other factors. Several years ago in
Oregon a population study oflung cancer incidence
was done. A major factor found to be important
and characteristic was occupation, for both sexes.
A key point here was that the occupational risk
seemed to be histology specific. In other words,
lung cancer is not a single disease, it is a group of
diseases. With regard to Dr. Kuller's illustration
of a socioeconomic effect on lung cancer, if you
break that down by histologic types you find that
some types go just the reverse. He thought that
there is plenty of reason to look for other factors
contributing to lung cancer, and occupational ex-
posures are certainly a leading possibility.
Dr. Kuller responded by pointing out that even
if we might wish that if we stop smoking on
Monday, on Tuesday we would not get lung
cancer, unfortunately it doesn't work that way.
Because of direct effects of smoke products on the
coronary circulation, especially from carbon mon-
oxide and nicotine, for coronary disease there
might be acute effects which would be removed
immediately by stopping smoking, but actually the
British physician studies show a substantial period
oftime before a decline in vascular disease mortal-
ity occurs. Secondly, although we believe that we
have made an impact in getting people to quit
smoking, if one looks carefully at the data it turns
out a large proportion of the people who have quit
are those who were relatively light cigarette
smokers. Heavy cigarette smokers in the popula-
tion are not those likely to quit, unfortunately. In
addition, for lung cancer there are significant
cohort phenomena, in the sense that each succeed-
ing cohort up until the present time have been
heavier cigarette smokers than the previous co-
hort. We are now seeing a rise in the rates of lung
cancer in women.
His experience has not been that occupational
factors are critical in overall lung cancer risk. It is
very hard to find noncigarette-smoking lung can-
93cer cases in most communities, irrespective of the
histological type considered. There clearly are
occupational factors in lung cancer. For example,
in the steel industry the only lung cancer excess
that was clear was among coke oven workers, and
that was predominantly topside coke oven work-
ers. They had a high relative risk but in a very
small segment of that industrial population. To
deny that cigarette smoking is the chiefelement in
lung cancer would be wrong. Clearly, there are
other factors that are important. He thought that
despite rules and regulations reducing exposures
to carcinogens in the workplace in all of the
industries, if the men continue to smoke the way
they do now, these regulations will have a small
effect on lung cancer rates. Dr. Bundy added that
the fact that both males and females are starting
to smoke at earlier ages may be a significant factor
causing the lung cancer rate to continue to go up.
A critical length of time of exposure is reached
much sooner now, and this may be one of the
reasons a leveling off of the lung cancer rate has
not occurred in males.
Dr. Radford commented that even though we all
agree that more human epidemiologic studies are
needed for purposes of control of hazards, as a
matter of fact the funding situation is getting
worse. First, there is a cut-back generally in
research budgets. Secondly, the Congress is not
sympathetic to epidemiology, nor is the scientific
community, such as experimental biologists, phys-
icists and chemists, who often disbelieve epide-
miologic results. An important point about human
epidemiology is that you cannot actually replicate
an experiment, unlike the situation in laboratory
science. For this reason, it is imperative that data
obtained on large human studies have to be open
to review. Biases that may be present have to be
very carefully dealt with, which is why the point
that the IRLG guidelines raised about making
data available for scrutiny by one's peers is ex-
tremely important. How we can do this profes-
sionally is uncertain. He agreed with Dr. Bundy
that replication was critical in validating the re-
sults of human studies. One implication of that is
that you need at least two studies that are
reasonably in agreement before you can regulate.
Finally, with regard to the use of the National
Academy of Sciences as an "impartial" arbiter of
scientific truth, he believed that the Academy has
become just as politicized as any other group. The
NAS can get out of its reports anything that it
wants to, depending on who is selected to serve on
the committees preparing them.
Dr. Marvin Schneiderman asked to show some
data that relate to what Dr. Bundy said about the
trend of cancer rates in relation to the significance
of occupationally induced cancers. Table 1 gives
cancer incidence data for white males, age-adjusted
to the 1970 United States population, comparing
rates for 1969-71 to 1976. Cancer incidence (as well
as mortality) data all show increases over the time
period 1969-76, for black males (not shown) even
greater than for white males. To prepare Table 1,
he had first isolated the forms of cancer that he
and others have indicated were likely to be
industrially related and those not likely to be
industrially related. Two groups of cancers were
included in the occupationally related category:
those more likely to be work-related and those less
likely. Then he had corrected the rates for these
possible occupational cancers that could be related
to cigarette smoking (and also exposure to sun-
shine because he had included melanomas), for the
effects of these known risk factors. The subhead-
ing entitled "other" included not only the remain-
ing cancer types, but also that portion of lung,
bladder and pancreatic cancers and melanoma
attributable to smoking and sunlight exposure.
For those cancer types identified as more likely to
Table 1. Changes in cancer incidence, U.S. white males, 1969-71 through 1976. Rates per 100,000 age-corrected to 1970.a
Rate per 100,000 Average
1969-71 1976 annual change, %b
Sites "more likely" to be related to occupationc 55.0 69.5 +4.0
Sites "less likely" to be related to occupationd 70.9 75.8 + 1.1
Total sites likely to be related to occupation 125.9 145.3 +2.4
Total otherse 216.6 228.7 +0.9
Total all sites 342.5 374.0 +1.5
aData sources: 1969-71: Third National Cancer Survey; 1976: SEER (NCI).
bAverage annual percentage change calculated from slope of linear regression fitted to annual incidence data.
cCancers oflung, urinary tract and liver, plus lymphomas and melanoma.
dCancers ofstomach, lower intestinal tract (including rectum) and of the pancreas. Note: Smoking effects removed for cancers of
lung, bladder and pancreas, and effect of sunlight corrected for melanomas.
elncludes all other sites, plus portions of lung, bladder, pancreas and melanoma attributed to smoking and sunlight.
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crease for white males has been more than four
times as great as for the "other" category. The
less likely sites, primarily intestinal tract cancers,
showed only a slight difference.
Dr. Schneiderman said that the important con-
clusion about these results was that in commenting
about whether cancer trends are changing or not,
one should use up-to-date data. Also changes in
cancer incidence are more important than changes
in cancer mortality. He thought it was most
inappropriate for Dr. Philip Handler or other
people to talk about changes in cancer mortality
that have occurred in the last 40 or 50 years, and
not talk about the changes in incidence that have
occurred in the last seven or eight years.
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